Home Page - 2026 Tucson Annual Conference on Advances in Hematology & Oncology

The 2026 Tucson Annual Conference on Advances in Hematology & Oncology is a one-day, CME-accredited educational program designed to provide clinicians with a focused update on rapidly evolving therapeutic strategies and evidence-based management across malignant hematology and solid tumors. This meeting brings together leading experts to review practice-changing clinical trial data, emerging targeted and cellular therapies, and recent updates to national and international treatment guidelines.

Through a combination of didactic presentations, case-based discussions, and interactive panel dialogue, the conference emphasizes translating new evidence into practical, real-world clinical decision-making. Participants will gain insights into optimizing treatment selection, personalizing care based on disease biology and patient-specific factors, and incorporating novel agents and updated standards into routine oncology practice.

This activity is intended to enhance clinicians’ ability to critically evaluate new data and confidently integrate advances that improve patient outcomes while navigating the complexities of modern cancer care.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

Tucson Marriott University Park